Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents. [electronic resource]
Producer: 20011214Description: 79-86 p. digitalISSN:- 1040-8428
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antigens, CD -- immunology
- Antigens, Differentiation, B-Lymphocyte -- immunology
- Antigens, Neoplasm -- immunology
- Cell Adhesion Molecules
- Humans
- Immunotoxins -- chemistry
- Lectins
- Lymphoma, B-Cell -- drug therapy
- RNA -- metabolism
- Ribonucleases -- therapeutic use
- Sialic Acid Binding Ig-like Lectin 2
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.